Xeris Biopharma Holdings (XERS) Net Equity Issued and Repurchased (2021 - 2026)
Xeris Biopharma Holdings (XERS) recorded Net Equity Issued and Repurchased of $600,000 in Q2 2026, down 38.3% from $972,000 a year earlier and down 91.8% from the prior quarter.
Powered by 
Analysis
Xeris Biopharma Holdings (XERS) Net Equity Issued and Repurchased (2021 - 2026) Analysis & Trends
On a TTM basis, Xeris Biopharma Holdings' Net Equity Issued and Repurchased came in at $13.68 million as of Jun 30, 2026, up 114.8% year-over-year; for FY2025, it came in at $11.58 million, up 830.7% from FY2024.
- Annual Net Equity Issued and Repurchased has a five-year compound annual growth rate of -29.4% (FY2020 to FY2025).
- Across earlier years, Net Equity Issued and Repurchased came in at $1.24 million in FY2024 (+126.6%), $549,000 in FY2023 (-98.2%), $30 million in FY2022 (+11.1%) and $27 million in FY2021 (-59.0%).
- Quarterly Net Equity Issued and Repurchased has ranged from $251,000 in Q2 2024 to $30 million in Q1 2022 over the past five years.
- On a year-over-year basis, Net Equity Issued and Repurchased rose in four of the last five quarters, with growth averaging 253.6%.
- Per Business Quant, the preceding three quarters came in at $7.33 million (Q1 2026), $584,000 (Q4 2025) and $5.16 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Equity Issued (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,082.65 Bn | 1,051.23 Bn | 19.71 Bn | - |
| 2 | Johnson & Johnson | 623.68 Bn | 542.21 Bn | 17.26 Bn | - |
| 3 | AbbVie | 459.43 Bn | 432.59 Bn | 12.70 Bn | - |
| 4 | Merck | 354.80 Bn | 309.23 Bn | 12.21 Bn | 43.00 Mn |
| 5 | Novartis Ag | 269.16 Bn | 225.03 Bn | 11.24 Bn | - |
| 6 | Astrazeneca | 244.40 Bn | 217.97 Bn | 12.86 Bn | 6.00 Mn |
| 7 | Amgen | 220.17 Bn | 175.57 Bn | 7.24 Bn | - |
| 8 | Gilead Sciences | 183.05 Bn | 157.16 Bn | 6.22 Bn | 9.00 Mn |
| 9 | Pfizer | 160.27 Bn | 107.22 Bn | 10.94 Bn | - |
| 10 | Xeris Biopharma Holdings | 1.61 Bn | 1.17 Bn | 79.59 Mn | 600,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 600,000.00 |
| Mar 31, 2026 | 7.33 Mn |
| Dec 31, 2025 | 584,000.00 |
| Sep 30, 2025 | 5.16 Mn |
| Jun 30, 2025 | 972,000.00 |
| Mar 31, 2025 | 4.86 Mn |
| Dec 31, 2024 | 534,000.00 |
| Jun 30, 2024 | 251,000.00 |
| Mar 31, 2024 | 459,000.00 |
| Jun 30, 2023 | 549,000.00 |
| Mar 31, 2022 | 30.00 Mn |
| Mar 31, 2021 | 27.00 Mn |
API Access
Xeris Biopharma Holdings Net Equity Issued and Repurchased API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=net-equity-issued-and-repurchased&ticker=XERS&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "net-equity-issued-and-repurchased", "ticker": "XERS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=net-equity-issued-and-repurchased&ticker=XERS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();